Home > Insider Trading > Filing (0000919574-13-000298)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1344413	Alexza Pharmaceuticals Inc.	ALXA	Pharmaceutical Preparations (2834)	770567768

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1536071	Gmbh Austria Partners Lansdowne	Wallnerstrasse 3/21 Wien C4 1010		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock $0.0001 Par Value Per Share	Disposition	2013-01-17	100,000	$4.75	1,545,055	No	4	S	Indirect	See footnote
Common Stock, $0.0001 Par Value Per Share	Disposition	2013-01-18	25,000	$4.75	1,520,055	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

These reported securities are held in the accounts of several investment funds (collectively, the "Investment Funds") for which Lansdowne Partners Austria GmbH ("LPA") serves as either investment manager or investment advisor. LPA may be deemed to beneficially own the securities held by the Investment Funds by virtue of LPA's position as investment manager or investment advisor of the Investment Funds. LPA disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that LPA is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.